发明公开
- 专利标题： PROGNOSIS PREDICTION FOR MELANOMA CANCER
- 专利标题（中）： PROGNOSESTELLUNGFÜRMELANOM
-
申请号： EP08766967.7申请日： 2008-05-23
-
公开(公告)号： EP2158332A1公开(公告)日： 2010-03-03
- 发明人: BLACK, Michael Alan , CEBON, Jonathan , GUILFORD, Parry John , JOHN, Thomas
- 申请人： Pacific Edge Biotechnology Limited , LUDWIG INSTITUTE FOR CANCER RESEARCH
- 申请人地址： C/-Deloitte 8th Floor, Otago House 481 Moray Place Dunedin NZ
- 专利权人： Pacific Edge Biotechnology Limited,LUDWIG INSTITUTE FOR CANCER RESEARCH
- 当前专利权人： Pacific Edge Biotechnology Limited,LUDWIG INSTITUTE FOR CANCER RESEARCH
- 当前专利权人地址： C/-Deloitte 8th Floor, Otago House 481 Moray Place Dunedin NZ
- 代理机构： Wright, Simon Mark
- 优先权： NZ55536307 20070524
- 国际公布： WO2008143533 20081127
- 主分类号： C12Q1/68
- IPC分类号： C12Q1/68
摘要：
The invention relates to prognostic markers and prognostic signatures, and compositions and methods for determining the prognosis of cancer in a patient, particularly for melanoma. Specifically, the invention relates to the use of genetic and protein markers for the prediction of the risk of progression of a cancer, such as melanoma, based on markers and signatures of markers. In various aspects, the invention provides methods, compositions, kits, and devices based on prognostic cancer markers, specifically melanoma prognostic markers, to aid in the prognosis and treatment of cancer.
公开/授权文献
- EP2158332B1 PROGNOSIS PREDICTION FOR MELANOMA CANCER 公开/授权日：2017-01-18
信息查询
